These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15971545)

  • 21. Analytical procedure validation and the quality by design paradigm.
    Rozet E; Lebrun P; Michiels JF; Sondag P; Scherder T; Boulanger B
    J Biopharm Stat; 2015; 25(2):260-8. PubMed ID: 25357001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Market surveillance study on general method 2.9.40. uniformity of dosage units, carried out by the OMCL Network of the EDQM/Council of Europe.
    Botella SM; Spieser JM; Daas A
    Pharmeur Sci Notes; 2007 Sep; 2007(1):21-32. PubMed ID: 17993091
    [No Abstract]   [Full Text] [Related]  

  • 24. Statistical considerations in setting product specifications.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
    Scott B; Wilcock A
    PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A European perspective on orally inhaled products: in vitro requirements for a biowaiver.
    García-Arieta A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A liquid chromatographic method using a reversed-phase hybrid stationary phase to control potential impurities of imipramine hydrochloride.
    Dixon SP; La Torre F; Lodi A; Miller JH; Skellern GG
    Pharmeur Sci Notes; 2006 Dec; 2006(2):35-9. PubMed ID: 17691212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Batch variability of bacitracin: HPLC versus MEKC.
    Weber C; Matingen S; Holzgrabe U
    Pharmeur Sci Notes; 2005 Aug; 2005(1):47-51. PubMed ID: 17687894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carryover negligibility and relevance in bioequivalence studies.
    Ocaña J; Sanchez O MP; Carrasco JL
    Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quality by design approach for longitudinal quality attributes.
    Lebrun P; Giacoletti K; Scherder T; Rozet E; Boulanger B
    J Biopharm Stat; 2015; 25(2):247-59. PubMed ID: 25360720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equivalence testing for parallelism in the four-parameter logistic model.
    Jonkman JN; Sidik K
    J Biopharm Stat; 2009 Sep; 19(5):818-37. PubMed ID: 20183446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of reference extracts in quality control of traditional Chinese medicines].
    Lu TL; Zhai WM; Cai BC; Zhou Y; Mao CQ; Li L
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):462-5. PubMed ID: 23668030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).
    Dobbelaer R; Daas A; Milne C
    Pharmeuropa Bio; 2004 Jan; 2003(2):77-90. PubMed ID: 14960264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two approaches for treating cascade impaction mass balance measurements.
    Wyka B; Tougas T; Mitchell J; Strickland H; Christopher D; Lyapustina S
    J Aerosol Med; 2007; 20(3):236-56. PubMed ID: 17894532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precision of the reportable value-Statistical optimization of the number of replicates.
    Burdick RK; Ermer J
    J Pharm Biomed Anal; 2019 Jan; 162():149-157. PubMed ID: 30240988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using tolerance intervals for assessment of pharmaceutical quality.
    Dong X; Tsong Y; Shen M; Zhong J
    J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.